Complete Genomics News

GATC Biotech and Complete Genomics, Inc., today announced the execution of a research collaboration agreement to sequence several human genomes from samples provided by GATC.

Complete Genomics , a closely held company in Silicon Valley, produced complete sequences of three peoplea s DNA at an average cost of $4,500, accelerating the race to develop faster, cheaper gene-mapping systems.

DNA sequencing can shows illnesses you're predisposed to contract or let doctors tailor medicines just for you.

The Institute for Systems Biology and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington's disease .

Under dim blue light, the 16 machines work like self-contained robotic laboratories.

Just a month ago Stephen Quake sequenced his genome for $50000. That represents a drop of 80% from the $250k cost of a year ago and orders of magnitude lower than the cost 10 years ago.

Complete Genomics, a Mountain View startup, announced Tuesday that it had deciphered and delivered 14 full human genomes to customers that include pharmaceutical giant Pfizer and leading medical research institutes, a significant step for an industry whose work could revolutionize health care.

Complete Genomics Inc., a third-generation human genome sequencing company, announced that it has raised $45 million in private equity financing and closed its Series D funding round with two new investors - Essex Woodlands Health Ventures and OrbiMed Advisors, LLC.

Complete Genomics, a Silicon Valley-based startup that promises supercheap sequencing, announced Monday that it had raised $45 million in its latest round of venture funding.

Complete Genomics, a Mountain View startup with visions of becoming the Google of DNA sequencing, announced $45 million in fourth-round venture funding Monday as it ramps up plans to perform a stunning 10,000 gene sequences by the end of 2010 - one thousand times the number performed to date.

Complete Genomics Inc., a third-generation human genome sequencing company, announced that it has raised $45 million in private equity financing and closed its Series D funding round with two new investors - Essex Woodlands Health Ventures and OrbiMed Advisors, LLC.